← All verdicts
Verdict

Deep Overvalued

Every analyzed stock in Deep Overvalued1,218 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Deep Overvalued" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

AAP
ADVANCE AUTO PARTS INC
Deeply overvalued
Consumer Cyclical Risk 69 · High
Price$44.68
Model IV$14.14
P/IV4.26
Premium +216% Return to IV: -68.4%
Market implies +19.0%/yr vs model +3.0% · above model
AAPL
Apple Inc.
Deeply overvalued
Technology Risk 65 · High
Price$331.34
Model IV$115.28
P/IV2.71
Premium +187% Return to IV: -65.2%
Market implies +21.9%/yr vs model +8.8% · above model
ABCB
Ameris Bancorp
Deeply overvalued
Financial Services Risk 65 · High
Price$84.66
Model IV$64.14
P/IV1.31
Premium +32% Return to IV: -24.2%
ABLV
Able View Global Inc.
Deeply overvalued
Consumer Cyclical Risk 58 · Elevated
Price$0.98
Model IV$0.40
P/IV2.75
Premium +145% Return to IV: -59.2%
Market implies +12.1%/yr vs model +3.0% · above model
ABTC
American Bitcoin Corp.
Valuation N/A
Financial Services Risk 54 · Elevated
Price$8.32
Model IV
P/IV
Market implies +57.0%/yr vs model +50.0% · above model
ABX
Abacus Global Management, Inc.
Deeply overvalued
Financial Services Risk 65 · High
Price$9.33
Model IV$2.05
P/IV4.39
Premium +356% Return to IV: -78.1%
Market implies +19.7%/yr vs model +15.0% · above model
ABXL
Abacus Global Management, Inc.
Deeply overvalued
Financial Services Risk 59 · Elevated
Price$25.42
Model IV$6.93
P/IV3.68
Premium +267% Return to IV: -72.7%
Market implies +16.2%/yr vs model +50.0% · below model
ACA
Arcosa, Inc.
Deeply overvalued
Industrials Risk 60 · High
Price$145.15
Model IV$46.33
P/IV2.74
Premium +213% Return to IV: -68.1%
Market implies +22.8%/yr vs model +8.2% · above model
ACAD
ACADIA PHARMACEUTICALS INC
Deeply overvalued
Healthcare Risk 52 · Elevated
Price$26.76
Model IV$10.33
P/IV2.10
Premium +159% Return to IV: -61.4%
Market implies +27.1%/yr vs model +18.4% · above model
ACFN
ACORN ENERGY, INC.
Deeply overvalued
Industrials Risk 50 · Elevated
Price$21.62
Model IV$11.21
P/IV1.52
Premium +93% Return to IV: -48.1%
Market implies +14.4%/yr vs model +11.7% · in line
ACLS
AXCELIS TECHNOLOGIES INC
Deeply overvalued
Industrials Risk 58 · Elevated
Price$113.43
Model IV$30.66
P/IV4.91
Premium +270% Return to IV: -73.0%
Market implies +26.4%/yr vs model +8.0% · above model
ACR
ACRES Commercial Realty Corp.
Valuation N/A
Financial Services Risk 58 · Elevated
Price$13.56
Model IV
P/IV
Limited data — see page
ACTG
ACACIA RESEARCH CORP
Deeply overvalued
Financial Services Risk 67 · High
Price$4.57
Model IV$0.99
P/IV2.54
Premium +360% Return to IV: -78.2%
ACU
ACME UNITED CORP
Deeply overvalued
Industrials Risk 68 · High
Price$60.72
Model IV$16.96
P/IV2.49
Premium +258% Return to IV: -72.1%
Market implies +17.8%/yr vs model +3.2% · above model
ACVA
ACV Auctions Inc.
Deeply overvalued
Technology Risk 60 · High
Price$10.41
Model IV$1.80
P/IV3.64
Premium +477% Return to IV: -82.7%
Market implies +37.9%/yr vs model +18.1% · above model
ADAMG
ADAMAS TRUST, INC.
Deeply overvalued
Financial Services Risk 62 · High
Price$25.29
Model IV$12.17
P/IV2.07
Premium +108% Return to IV: -51.9%
ADAMH
ADAMAS TRUST, INC.
Deeply overvalued
Financial Services Risk 73 · High
Price$25.65
Model IV$12.17
P/IV2.11
Premium +111% Return to IV: -52.5%
ADAMI
ADAMAS TRUST, INC.
Deeply overvalued
Financial Services Risk 62 · High
Price$25.39
Model IV$12.17
P/IV2.09
Premium +109% Return to IV: -52.1%
ADAML
ADAMAS TRUST, INC.
Deeply overvalued
Financial Services Risk 62 · High
Price$24.84
Model IV$12.17
P/IV1.99
Premium +104% Return to IV: -51.0%
ADAMM
ADAMAS TRUST, INC.
Deeply overvalued
Financial Services Risk 62 · High
Price$25.60
Model IV$12.17
P/IV2.08
Premium +110% Return to IV: -52.5%
ADAMN
ADAMAS TRUST, INC.
Deeply overvalued
Financial Services Risk 73 · High
Price$24.53
Model IV$12.17
P/IV1.91
Premium +102% Return to IV: -50.4%
ADAMO
ADAMAS TRUST, INC.
Deeply overvalued
Financial Services Risk 62 · High
Price$25.23
Model IV$12.17
P/IV2.08
Premium +107% Return to IV: -51.8%
ADAMZ
ADAMAS TRUST, INC.
Deeply overvalued
Financial Services Risk 62 · High
Price$17.58
Model IV$11.32
P/IV1.62
Premium +55% Return to IV: -35.6%
ADEA
Adeia Inc.
Deeply overvalued
Communication Services Risk 68 · High
Price$24.66
Model IV$10.77
P/IV2.48
Premium +129% Return to IV: -56.3%
Market implies +16.6%/yr vs model +4.6% · above model
ADI
ANALOG DEVICES INC
Deeply overvalued
Technology Risk 53 · Elevated
Price$361.35
Model IV$139.94
P/IV2.96
Premium +158% Return to IV: -61.3%
Market implies +22.3%/yr vs model +11.1% · above model
ADTX
Aditxt, Inc.
Valuation N/A
Healthcare Risk 35 · Moderate
Price$0.01
Model IV
P/IV
Limited data — see page
AEO
AMERICAN EAGLE OUTFITTERS INC
Deeply overvalued
Consumer Cyclical Risk 59 · Elevated
Price$15.43
Model IV$10.66
P/IV1.48
Premium +45% Return to IV: -30.9%
Market implies +12.3%/yr vs model +8.1% · above model
AEYE
AUDIOEYE INC
Deeply overvalued
Technology Risk 66 · High
Price$7.93
Model IV$4.42
P/IV1.74
Premium +79% Return to IV: -44.3%
Market implies +11.4%/yr vs model +13.3% · in line
AFBI
Affinity Bancshares, Inc.
Deeply overvalued
Financial Services Risk 73 · High
Price$23.00
Model IV$14.14
P/IV1.59
Premium +63% Return to IV: -38.5%
AFCG
Advanced Flower Capital Inc.
Deeply overvalued
Unknown Risk 62 · High
Price$3.50
Model IV$0.92
P/IV4.06
Premium +281% Return to IV: -73.8%
Market implies +10.4%/yr vs model -7.5% · above model
AGL
agilon health, inc.
Deeply overvalued
Healthcare Risk 57 · Elevated
Price$89.77
Model IV$41.18
P/IV2.24
Premium +118% Return to IV: -54.1%
Market implies +16.8%/yr vs model +40.5% · below model
AGX
ARGAN INC
Overvalued
Industrials Risk 57 · Elevated
Price$388.74
Model IV$332.69
P/IV2.00
Premium +17% Return to IV: -14.4%
Market implies +15.1%/yr vs model +16.4% · in line
AGYS
AGILYSYS INC
Deeply overvalued
Technology Risk 57 · Elevated
Price$104.49
Model IV$55.53
P/IV1.56
Premium +88% Return to IV: -46.9%
Market implies +21.1%/yr vs model +16.5% · above model
AHG
Akso Health Group
Deeply overvalued
Technology Risk 50 · Elevated
Price$0.84
Model IV$0.39
P/IV3.90
Premium +115% Return to IV: -53.5%
Market implies +3.7%/yr vs model +50.0% · below model
AHR
American Healthcare REIT, Inc.
Deeply overvalued
Financial Services Risk 77 · High
Price$53.40
Model IV$26.16
P/IV1.87
Premium +104% Return to IV: -51.0%
AI
C3.ai, Inc.
Deeply overvalued
Technology Risk 57 · Elevated
Price$10.54
Model IV$2.93
P/IV3.68
Premium +260% Return to IV: -72.2%
Market implies +25.2%/yr vs model +20.7% · above model
AIDX
20/20 Biolabs, Inc.
Deeply overvalued
Industrials Risk 54 · Elevated
Price$0.56
Model IV$0.30
P/IV2.89
Premium +87% Return to IV: -46.4%
Market implies +1.6%/yr vs model +16.7% · below model
AIHS
Senmiao Technology Ltd
Deeply overvalued
Industrials Risk 52 · Elevated
Price$2.00
Model IV$0.77
P/IV1.53
Premium +161% Return to IV: -61.7%
Market implies +16.6%/yr vs model +9.6% · above model
AIN
ALBANY INTERNATIONAL CORP /DE/
Deeply overvalued
Consumer Cyclical Risk 58 · Elevated
Price$60.28
Model IV$37.46
P/IV1.73
Premium +61% Return to IV: -37.9%
Market implies +13.1%/yr vs model +9.1% · above model
AIR
AAR CORP
Deeply overvalued
Industrials Risk 59 · Elevated
Price$120.08
Model IV$77.34
P/IV1.46
Premium +55% Return to IV: -35.6%
Market implies +9.2%/yr vs model +13.9% · below model
AIRS
Airsculpt Technologies, Inc.
Deeply overvalued
Healthcare Risk 59 · Elevated
Price$2.42
Model IV$1.76
P/IV3.06
Premium +38% Return to IV: -27.4%
Market implies +9.3%/yr vs model +3.3% · above model
AIT
APPLIED INDUSTRIAL TECHNOLOGIES INC
Deeply overvalued
Industrials Risk 50 · Elevated
Price$323.78
Model IV$218.76
P/IV1.39
Premium +48% Return to IV: -32.4%
Market implies +11.9%/yr vs model +8.1% · above model
AJG
Arthur J. Gallagher & Co.
Deeply overvalued
Financial Services Risk 54 · Elevated
Price$248.04
Model IV$155.64
P/IV1.30
Premium +59% Return to IV: -37.3%
Market implies +13.2%/yr vs model +8.5% · above model
AKAM
AKAMAI TECHNOLOGIES INC
Deeply overvalued
Technology Risk 62 · High
Price$105.40
Model IV$77.64
P/IV1.93
Premium +36% Return to IV: -26.3%
Market implies +12.2%/yr vs model +10.1% · in line
AKBA
Akebia Therapeutics, Inc.
Deeply overvalued
Healthcare Risk 66 · High
Price$0.90
Model IV$0.64
P/IV1.64
Premium +41% Return to IV: -29.1%
Market implies +3.3%/yr vs model +2.0% · in line
ALB
ALBEMARLE CORP
Deeply overvalued
Basic Materials Risk 57 · Elevated
Price$113.45
Model IV$65.51
P/IV2.69
Premium +73% Return to IV: -42.3%
Market implies +14.2%/yr vs model +8.0% · above model
ALGN
ALIGN TECHNOLOGY INC
Deeply overvalued
Healthcare Risk 70 · High
Price$147.00
Model IV$54.97
P/IV3.18
Premium +167% Return to IV: -62.6%
Market implies +18.9%/yr vs model +5.7% · above model
ALH
Alliance Laundry Holdings Inc.
Deeply overvalued
Industrials Risk 55 · Elevated
Price$21.61
Model IV$16.00
P/IV1.58
Premium +35% Return to IV: -26.0%
Market implies +12.2%/yr vs model +10.1% · in line
ALL
ALLSTATE CORP
Deeply overvalued
Financial Services Risk 73 · High
Price$253.71
Model IV$98.86
P/IV2.08
Premium +157% Return to IV: -61.0%
ALNT
ALLIENT INC
Deeply overvalued
Healthcare Risk 53 · Elevated
Price$91.28
Model IV$33.31
P/IV2.38
Premium +174% Return to IV: -63.5%
Market implies +21.0%/yr vs model +8.8% · above model
ALRM
Alarm.com Holdings, Inc.
Deeply overvalued
Technology Risk 46 · Elevated
Price$55.36
Model IV$33.46
P/IV1.35
Premium +65% Return to IV: -39.6%
Market implies +14.2%/yr vs model +9.1% · above model
ALRS
ALERUS FINANCIAL CORP
Deeply overvalued
Financial Services Risk 73 · High
Price$33.37
Model IV$14.35
P/IV1.99
Premium +133% Return to IV: -57.0%
ALTI
AlTi Global, Inc.
Deeply overvalued
Financial Services Risk 54 · Elevated
Price$3.29
Model IV$6.54
P/IV1.51
Discount 50% Return to IV: +98.7%
Market implies -12.2%/yr vs model +35.5% · below model
ALV
AUTOLIV INC
Deeply overvalued
Consumer Cyclical Risk 64 · High
Price$121.13
Model IV$82.01
P/IV1.55
Premium +48% Return to IV: -32.3%
Market implies +11.4%/yr vs model +7.4% · above model
AM
Antero Midstream Corp
Deeply overvalued
Utilities Risk 54 · Elevated
Price$22.06
Model IV$15.82
P/IV1.33
Premium +39% Return to IV: -28.3%
AME
AMETEK INC/
Deeply overvalued
Healthcare Risk 46 · Elevated
Price$241.87
Model IV$155.98
P/IV1.45
Premium +55% Return to IV: -35.5%
Market implies +12.7%/yr vs model +8.2% · above model
AMOD
ALPHA MODUS HOLDINGS, INC.
Valuation N/A
Financial Services Risk 73 · High
Price$2.24
Model IV
P/IV
Limited data — see page
AMPL
Amplitude, Inc.
Deeply overvalued
Technology Risk 53 · Elevated
Price$12.59
Model IV$5.07
P/IV1.54
Premium +148% Return to IV: -59.7%
Market implies +13.1%/yr vs model +19.7% · below model
AMRC
Ameresco, Inc.
Deeply overvalued
Industrials Risk 53 · Elevated
Price$23.78
Model IV$24.19
P/IV1.49
Discount 2% Return to IV: +1.7%
Market implies +8.3%/yr vs model +11.9% · below model
AMRZ
Amrize Ltd
Deeply overvalued
Industrials Risk 50 · Elevated
Price$40.52
Model IV$29.27
P/IV1.86
Premium +38% Return to IV: -27.8%
Market implies +7.3%/yr vs model +3.0% · above model